Federal contract award
36C26025F0024
BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO).
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 260-NETWORK CONTRACT OFFICE 20 (36C260) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79721D0166 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $379.9K |
| Current contract value | $379.9K |
| Potential contract value / ceiling | $379.9K |
| Start date | Oct 1, 2024 |
| Current end date | Sep 30, 2025 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | Aug 20, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 20, 2025 | P00002 | $29.4K | BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO). |
| Jul 18, 2025 | P00001 | $4.7K | BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO). |
| Oct 1, 2024 | 0 | $345.8K | BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO). |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.